RCM
OMIC

Revelation Capital Management’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Revelation Capital Management’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.54M Hold
47,195
– – 83.16% 1
2022
Q2 		$5.41M Sell
47,195
-26,803
-36% -$3.14M 76.54% 1
2022
Q1 		$14M Sell
73,998
-100,000
-57% -$23.1M 51.22% 1
2021
Q4 		$60.3M Buy
+173,998
New +$67.4M 58.21% 1

Other funds holding OMIC

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

Revelation Capital Management's OMIC Position: Q3 2022 in Review

Revelation Capital Management held its Singular Genomics Systems, Inc. Common Stock (OMIC) position steady in Q3 2022 at 47,195 shares worth $3.54M. The position accounts for 83.16% of the portfolio, ranked #1.

Revelation Capital Management first reported a position in OMIC in Q4 2021 and has held it in 4 quarters since. The position peaked at $60.3M in Q4 2021. 74 funds tracked by Wall St. Rank hold OMIC as of Q3 2022.

  • Revelation Capital Management held 47,195 shares of Singular Genomics Systems, Inc. Common Stock worth $3.54M as of Q3 2022.
  • Revelation Capital Management left its Singular Genomics Systems, Inc. Common Stock share count unchanged in Q3 2022.
  • Singular Genomics Systems, Inc. Common Stock made up 83.16% of Revelation Capital Management's portfolio in Q3 2022, its #1 holding.
  • Revelation Capital Management first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and has held it in 4 quarters since.
  • Revelation Capital Management's Singular Genomics Systems, Inc. Common Stock position peaked at $60.3M in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2022.

Based on Revelation Capital Management's 13F filing for Q3 2022, filed 7 Nov 2022.